On February 18, 2018, OWC Pharmaceutical Research Corp. appointed Dr. Oron Yacoby Zeevi as its Chief Scientific Officer (CSO). Dr. Yehuda Baruch, who served as the Registrant’s CSO will now serve as Chief Medical and Regulatory Officer. Dr. Yacoby Zeevi has more than 20 years of extensive scientific experience with both private and publicly listed companies in the biopharmaceutical industry. In 2008, Dr. Yacoby Zeevi joined Neuroderm Ltd. as the Vice President of Research and was promoted to the position of VP R&D. From October 2016 until her recent departure, she served as Chief Scientific Officer of Neuroderm, which was sold to Mitsubishi Tanabe Pharma for USD 1.1 billion in July 2017.